These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 3677767)
1. Inadequacy of standard aminoglycoside loading doses in acutely ill patients. Chelluri L; Jastremski MS Crit Care Med; 1987 Dec; 15(12):1143-5. PubMed ID: 3677767 [No Abstract] [Full Text] [Related]
2. Impact of altered aminoglycoside volume of distribution on the adequacy of a three milligram per kilogram loading dose. Critical Care Research Group. Dorman T; Swoboda S; Zarfeshenfard F; Trentler B; Lipsett PA Surgery; 1998 Jul; 124(1):73-8. PubMed ID: 9663254 [TBL] [Abstract][Full Text] [Related]
3. Altered aminoglycoside pharmacokinetics in the critically ill. Beckhouse MJ; Whyte IM; Byth PL; Napier JC; Smith AJ Anaesth Intensive Care; 1988 Nov; 16(4):418-22. PubMed ID: 3232800 [TBL] [Abstract][Full Text] [Related]
4. Aminoglycoside antibiotic agents: a review. Spelman DW; McDonald M; Spicer WJ Med J Aust; 1989 Sep; 151(6):346-9. PubMed ID: 2687667 [No Abstract] [Full Text] [Related]
5. Aminoglycoside antibiotics in clinical use. Pancoast SJ Med Clin North Am; 1988 May; 72(3):581-612. PubMed ID: 3280908 [TBL] [Abstract][Full Text] [Related]
6. The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients. Mueller EW; Boucher BA Surg Infect (Larchmt); 2009 Dec; 10(6):563-70. PubMed ID: 20035611 [TBL] [Abstract][Full Text] [Related]
7. Effect of altered volume of distribution on aminoglycoside levels in patients in surgical intensive care. Niemiec PW; Allo MD; Miller CF Arch Surg; 1987 Feb; 122(2):207-12. PubMed ID: 3813869 [TBL] [Abstract][Full Text] [Related]
8. Experience with a once-daily dosing program of aminoglycosides in critically ill patients. Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533 [TBL] [Abstract][Full Text] [Related]
9. [Theoretical research for therapy of infection]. Shimizu K Nihon Sanka Fujinka Gakkai Zasshi; 1991 Aug; 43(8):815-23. PubMed ID: 1655924 [TBL] [Abstract][Full Text] [Related]
10. [Factors affecting the pharmacokinetics of aminoglycoside antibiotics]. Dyderski S Wiad Lek; 1989 Jul 1-15; 42(13-15):919-23. PubMed ID: 2634321 [No Abstract] [Full Text] [Related]
11. [New methods of administration of cephalosporins and aminoglycosides: relations between pharmacokinetics and pharmacodynamics]. Kamnev IuV Antibiot Khimioter; 1992 Feb; 37(2):44-50. PubMed ID: 1514855 [No Abstract] [Full Text] [Related]
12. Infection control series: III. Clinical application of aminoglycoside drug levels. Leonard RF W V Med J; 1981 May; 77(5):105-10. PubMed ID: 6243027 [No Abstract] [Full Text] [Related]
13. A multicenter comparative trial of aztreonam in the treatment of gram-negative infections in compromised intensive-care patients. Rabinad E; Bosch-Perez A Chemotherapy; 1989; 35 Suppl 1():1-7. PubMed ID: 2659288 [TBL] [Abstract][Full Text] [Related]
18. Single daily dosing of aminoglycosides: a commentary. Rotschafer JC; Rybak MJ Ann Pharmacother; 1994 Jun; 28(6):797-801. PubMed ID: 7919572 [No Abstract] [Full Text] [Related]
19. Optimizing aminoglycoside use. Craig WA Crit Care Clin; 2011 Jan; 27(1):107-21. PubMed ID: 21144989 [TBL] [Abstract][Full Text] [Related]
20. A smart aminoglycoside hydrogel with tunable gel degradation, on-demand drug release, and high antibacterial activity. Hu J; Quan Y; Lai Y; Zheng Z; Hu Z; Wang X; Dai T; Zhang Q; Cheng Y J Control Release; 2017 Feb; 247():145-152. PubMed ID: 28077265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]